Episode 66: repurposed antivirals, banlamivimab for outpatients, and convalescent serum, all for COVID-19 episode artwork

EPISODE · Dec 12, 2020 · 26 MIN

Episode 66: repurposed antivirals, banlamivimab for outpatients, and convalescent serum, all for COVID-19

from Primary Care Update · host Mark Ebell

This is an all-COVID-19 week. We discuss the WHO Solidarity trial of remdesivir and other antivirals, banlamivimab for outpatients, and an RCT of convalescent serum. 

This is an all-COVID-19 week. We discuss the WHO Solidarity trial of remdesivir and other antivirals, banlamivimab for outpatients, and an RCT of convalescent serum.

NOW PLAYING

Episode 66: repurposed antivirals, banlamivimab for outpatients, and convalescent serum, all for COVID-19

0:00 26:47

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Primary Care Update?

This episode is 26 minutes long.

When was this Primary Care Update episode published?

This episode was published on December 12, 2020.

What is this episode about?

This is an all-COVID-19 week. We discuss the WHO Solidarity trial of remdesivir and other antivirals, banlamivimab for outpatients, and an RCT of convalescent serum. 

Can I download this Primary Care Update episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!